REQUEST A DEMO
Total
USD $0.00
Search more companies

Medcin Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Medcin Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medcin Pharma Sdn. Bhd specializes in neuro interventional radiology and clinical grade skincare products, with two main business segments: Radiology and Pharmaceuticals. They aim to gain recognition and trust from the medical community and serve clinicians in the medical field. Medcin Pharma offers products such as ALN Vena Cava Filter with Hook 2 in1 RS, Raysafe X2 Prestige, and Gel-Pro Medical Anti-fatigue Mat.

Headquarters
H-G-3A,Blok H,Sekitar 26, Persiaran Hulu Selangor,, Seksyen 26
Shah Alam; Selangor; Postal Code: 40400

Contact Details: Purchase the Medcin Pharma Sdn. Bhd. report to view the information.

Website: http://medcinpharma.com

Basic Information
Outstanding Shares:
Purchase the Medcin Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Medcin Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Medcin Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
July 23, 2002
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
71.43%
Purchase this report to view the information.
28.57%
Company Performance
Financial values in the chart are available after Medcin Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
7.61%
Total operating revenue
7.61%
Operating profit (EBIT)
-16.87%
Net Profit (Loss) for the Period
-17.08%
Total assets
-4.68%
Total equity
12.69%
Operating Profit Margin (ROS)
-4.26%
Net Profit Margin
-3.26%
Return on Equity (ROE)
-5.55%
Quick Ratio
4.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?